Weight Loss
Body Composition and GLP-1: Why Muscle Mass Matters for Women
Min Read
If you are using a GLP-1 receptor agonist for weight management and are considering pregnancy in the near future, this is a conversation you need to have with your doctor before you start trying to conceive. Current guidance is clear that GLP-1 medications should be discontinued before pregnancy — and understanding the timeline, the reasoning, and what to expect when you stop is important for planning.
GLP-1 receptor agonists — including semaglutide (Wegovy/Ozempic), liraglutide (Saxenda), and tirzepatide (Mounjaro) — are not approved for use during pregnancy. The key concern is not a documented catalogue of harm in humans, but a lack of adequate safety data and signals from animal studies that are sufficient to advise against use.
Animal reproductive studies on semaglutide have shown adverse effects at doses that are not directly comparable to human doses, including effects on early embryonic development. These findings are considered sufficient to advise avoidance during pregnancy as a precautionary principle. The same precautionary logic applies across GLP-1 medications.
There is also a physiological concern: GLP-1 medications reduce calorie intake and can affect nutrient absorption patterns during a phase of life when adequate nutritional intake is essential for foetal development.
For all these reasons, current clinical guidance advises discontinuation before attempting conception — not simply if you discover you are pregnant.
Current guidance from the product information for semaglutide (Wegovy) recommends discontinuation at least two months before a planned pregnancy. This timeline is based on the drug's elimination half-life — the time it takes for the body to clear the medication — which for semaglutide is approximately one week. Two months provides roughly eight half-lives, ensuring the medication has been substantially eliminated before conception.
For tirzepatide (Mounjaro), a similar precautionary period applies. Liraglutide (Saxenda) has a shorter half-life and may require a shorter washout period, but the same principle applies.
These timelines are minimum guidance. Your doctor may recommend a longer period depending on your individual circumstances — particularly if you have conditions where stopping GLP-1 may need to be coordinated with adjustments to other treatments (for example, if you have type 2 diabetes managed with the same medication).
Two months is not a long time, but it is enough time to affect preconception planning. Factor this into your timeline: if you plan to start trying to conceive in a given month, you should discuss stopping with your doctor approximately two to three months earlier.
Women on GLP-1 medications who are not planning pregnancy need to use effective contraception. There are two specific considerations:
Oral contraceptive absorption: GLP-1 medications slow gastric emptying, which may reduce the absorption of oral medications taken at the same time — including combined oral contraceptive pills. The clinical significance of this interaction on contraceptive efficacy is not fully established, but some guidelines advise women to take their pill at least one hour before or four hours after their GLP-1 injection to minimise potential interaction. Non-oral contraceptive methods (IUD, implant, injection) avoid this concern entirely.
GLP-1 and improved fertility: For women with PCOS, GLP-1 medications may improve ovulation by reducing insulin resistance and body weight. Women who previously had irregular cycles may find their fertility changes more than expected on GLP-1. Reliable contraception is essential unless pregnancy is planned.
One of the most common concerns women raise when discussing stopping GLP-1 medication is weight regain. This concern is clinically valid: research has shown that a significant proportion of weight lost on semaglutide is regained within one to two years of stopping, in the absence of substantial lifestyle changes.
This does not mean the medication's benefits are erased — but it does mean that the period between stopping GLP-1 and conceiving, the duration of pregnancy itself, and the postpartum period represent a time of real risk for weight regain. Discussing a plan with your doctor before stopping — including dietary and physical activity guidance for the preconception period — is important.
After delivery and the postpartum period, GLP-1 medications may potentially be restarted once breastfeeding has ended, depending on your health profile and goals. This is a conversation for your postpartum medical review.
If you are on a GLP-1 medication and are thinking about pregnancy — even in the next year — raise it with a Singapore-licensed doctor now. Two months may feel like a long advance notice but it allows proper planning, contraception review, and transition support. Stopping without medical guidance is not recommended.
How long before trying to conceive should I stop semaglutide? Current product guidance recommends stopping semaglutide at least two months before attempting conception, based on the medication's elimination half-life. Your doctor may recommend a longer period depending on your individual circumstances. Plan this conversation with your doctor two to three months ahead of your intended start date for trying to conceive.
Will I gain weight when I stop GLP-1 before pregnancy? Weight regain after stopping GLP-1 medication is common, with research showing significant rebound in many patients over one to two years of stopping. The degree varies and depends on lifestyle factors. Your doctor can help you develop a plan for the preconception period to minimise regain while ensuring adequate nutrition for pregnancy preparation.
Can I restart GLP-1 medication after having a baby? GLP-1 medications are not recommended during breastfeeding due to insufficient safety data. Once breastfeeding has ended, restarting GLP-1 treatment may be appropriate depending on your health profile. Discuss this in your postpartum medical review — do not restart without medical assessment.
Zoey is a doctor-led telehealth platform for women's health in Singapore. Consultations with Singapore-licensed doctors available online. Treatments are prescription-only medicines (POMs) and require medical assessment.
Articles featured on Zoey are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider. If you're looking for a healthcare provider, click here.
